retatrutide availability 2025 and the Grey Market: Buyer Beware – Sarah Hormachea Retatrutide UK: New Triple-Agonist Weight

Retatrutide acts on three hormone receptors GLP-1, GIP, and glucagon whereas Ozempic acts on GLP-1 alone

RESEARCH USE ONLY STATEMENT Umbrella Labs retatrutide is sold strictly for laboratory developmental research use only

Retatrutide, a newer triple receptor agonist, produces even more dramatic weight loss than tirzepatide in clinical trials, and hair loss on retatrutide follows the same pattern, correlating with weight loss magnitude rather than drug mechanism

As these drugs soar in popularity, researchers and physicians are finding uses form them outside the realm of obesity and diabetes

Protein intake for optimal muscle maintenance